title: Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.
authors.affiliation: Maria Cecilia Hospital - GVM Care and Research, Ettore Sansavini Health Science Foundation, Via Corriera 1, 48010 Cotignola (RA), Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Tavazzi
authors.forename: Aldo P
authors.initials: AP
authors.lastname: Maggioni
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Borer
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D057911:Angiotensin Receptor Antagonists / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D015415:Biomarkers / Q000378:metabolism; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D002316:Cardiotonic Agents; D000451:Mineralocorticoid Receptor Antagonists